A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity
Status:
Completed
Trial end date:
2002-01-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to compare the effects of Topiramate and placebo on abdominal
visceral fat accumulation at 6 months and to evaluate the safety of Topiramate for up to 12
months of continued treatment in male patients with abdominal obesity.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.